- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07432646
"Finding Solid Ground" in Inpatient Treatment for Dissociative Disorder Patients Followed by Transition to Outpatient Treatment Settings: A 1-year Follow-up Pilot Study
March 7, 2026 updated by: Modum Bad
Inpatient Group and Individual Trauma- and Dissociation Informed Stabilization Therapy for Adult Survivors of Childhood Trauma
The purpose of the pilot is to examine the usefulness of the psychoeducational program, Finding Solid Ground, for patients with dissociative disorders in a naturalistc observational study, involving a 3-months inpatient treatment followed by patients continuation with the program in their local outpatient settings, by examining outcome of main trauma-related symptoms and adaptive coping.
In addition, performing focus-group interviews with the patient groups at discharge and at follow-up, to gain information on their subjective experiences from participating in the program.
The patients' therapists in the outpatient settings are invited to give written feedback on their experiences from working with FSG.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Adult survivors of childhood trauma have complex and diverse symptoms profiles.
A subgroup develop a complex dissociative disorder.
Modum Bad has for years offered a 3-months inpatient treatment program for this patient group.
Patients leave the hospital after this treatment period and continue with treatment in their local outpatient settings.
They come back for a 5-days follow-up 9 months after discharge from the residential setting.
The aim of the pilot study is to examine changes in posttraumatic and dissociative symptoms and adaptive coping in this patient-group within the described naturalistic context, following patients' participation in Finding Solid Ground (FSG).
FSG is developed by dr Bethany Brand, dr.
Hygge Schielke, and dr Ruth Lanius (2022), and designed for this patient-group.
It has 30 topics.
Patients start up with FSG and complete 8 topics in the inpatient setting, and are offered to continue with the remaining topics during the outpatient period in collaboration with local treatment providers.
32 patients were recruited.
Two of them were not included: one did not want to participate, and the other patient had a different focus in her treatment than FSG.
Patients were assigned from referrals to the residential Department for Trauma treatment, Modum Bad, in Norway.
As part of the usual clinical practice they were referred to our treatment group if they had a complex dissociative disorder in need of stabilization.
The inpatient treatment lasts for 11 weeks and combines group- and individual therapies with different treatment modalities, all within the framework of FSG.
Patients came back for a 5-days follow-up stay, 9 months after discharge from the inpatient treatment.
Study Type
Observational
Enrollment (Actual)
30
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Buskerud
-
Vikersund, Buskerud, Norway, 3370
- Modum Bad, Psychiatric clinic
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
They are selected from patients referred to treatment in the Department for Trauma Treatment, Modum Bad, and have been routinely evaluated for treatment in this department, diagnosed with a dissociative disorder and in need of stabilisational interventions.
Description
Inclusion Criteria:
- The study include adults (minimum age of 18 years) with a complex dissociative disorder related to childhood trauma. All patients had received outpatient therapy with insufficient effect. Patients were diagnosed with at DSM-IV dissociative disorder, transformed to the ICD-10 dissociative disorders.
Exclusion Criteria:
- Ongoing psychosis, severe ongoing drug addiction, very disturbed group functioning, ongoing severe life crisis, mental disability, severe unsafe behavior (suicidality, self-harm).
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Adults with compelx dissociative disorders and histories of childhood trauma
All group and individual therapies were in line with the model presented in Finding Solid Ground, developed by dr.
Bethany Brand et al. (2022).
Patients were admitted for the inpatient pre-planned treatment for a 3-months period, continue with therapy in their local outpatient settings after discharge from the inpatient period, and come back for a 5-days follow-up stay 9 months after discharge from the inpatient treatment.
|
Patients are admitted in groups of eight.
During the 3-months inpatient treatment period, the program include a daily group session, and 3 weekly individual sessions with individual therapists and milieu-therapists, with focus on FSG-interventions from a trauma- and dissociation-informed perspective.
FSG follows the international guidelines (ISSTD, 2011) for treatment of dissociative disorders from the International Society for the Study of Trauma and Dissociation.
It uses different treatment modalities, such as live psychoeducation, psychoeducational videos, written and practical exercises, equine facilitated therapy, reflection and discussion groups.
They have parallel individual therapy with therapist (psychiatrist or psychologist) and milie-therapists, and participate in physical activity and ward meetings together with other patients in the unit.
All therapists are trained in trauma- and dissociation therory and treatment, as well as the FSG model.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Progress in Treatment Questionnaire (PITQ-p)
Time Frame: at respectively: baseline (T1); 3 months (T2); and 1-year follow-up (T3)
|
Asesses adaptive capacities.
It has 32 items scored on an 11-point scale ranging from 0% to 100%.
Scores are averaged.
Higher scores indicate higher capacitiy for adaptive coping.
|
at respectively: baseline (T1); 3 months (T2); and 1-year follow-up (T3)
|
|
PTSD Checklist for DSM-5 (PCL-5)
Time Frame: assessmentsat respectively: baseline (T1); 3 months (T2); and 1-year follow-up (T3)
|
Posttraumaticstress disorder checklist for DSM-5, scale and subscales.
Sum scores range from 20-80, with higher scores indicating greater PTSD symptoms severity
|
assessmentsat respectively: baseline (T1); 3 months (T2); and 1-year follow-up (T3)
|
|
Difficulties in emotion regulation scale (DERS)
Time Frame: assessments at respectively: baseline (T1); 3 months (T2); and 1-year follow-up (T3)
|
Difficulties in emotion regulation scale, scale and subscales.
It has 36 items ranging from 1 to 5. Scores are averaged.
Higher scores indicate higher level of difficulties in emotion regulation.
|
assessments at respectively: baseline (T1); 3 months (T2); and 1-year follow-up (T3)
|
|
Self-compassion Scale - Short Form (SCS-SF)
Time Frame: assessments at respectively: baseline (T1); 3 months (T2); and 1-year follow-up (T3)
|
Self-compassion scale short form (SCS-SF) has 12 items ranging from 1 to 5. Scores are averaged.
Total average socres are calculated after reverse scoring of relevant items, with higher scores indicating higher level of self-compassion.
|
assessments at respectively: baseline (T1); 3 months (T2); and 1-year follow-up (T3)
|
|
Dissociative Experiences Scale (DES-II)
Time Frame: assessments at respectively: baseline (T1); 3 months (T2); and 1-year follow-up (T3)
|
Dissociative experiences scale - version II has 28 items ranging from 0% to 100%.
Scores are averaged.
Higher scores indicate higher levels of dissociation.
|
assessments at respectively: baseline (T1); 3 months (T2); and 1-year follow-up (T3)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Hedonic deficits and interference scale (HDIS)
Time Frame: Assessment at respectively: 1) baseline (T1); 2) 3-months (T2); and 3) 1-year follow-up.
|
Includes three subscales; 1) Positive emotionality (PE); 2) Hedonic deficits (HD); 3) Negative affective interference (NAI).
All subscales are scored on a scale of 1 to 10.
The scores are averaged.
PE has 5 items, a higher score indicates higher levels of PE; HD has 5 items, a higher score indicates higher levels of HD; NAI has 11 items, a higher score indicates higher levels of negative affective interference.
|
Assessment at respectively: 1) baseline (T1); 2) 3-months (T2); and 3) 1-year follow-up.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Peter Sele, PhD candidate, Modum Bad, Research Institute, Vikersund, Buskerud, Norway
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Pierorazio, N. A., Robertson, J. L., Snyder,B. L., Brand, J. Schielke, H. J., & Lanius, R. A. (2025). Helpful aspects of a psychoeducational program for individuals with complex dissociation: An update for the Finding Solid Ground program. https://doi.org/10.1016/j.ejtd.2025.100566
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 1, 2023
Primary Completion (Actual)
June 10, 2025
Study Completion (Actual)
June 10, 2025
Study Registration Dates
First Submitted
December 17, 2025
First Submitted That Met QC Criteria
February 18, 2026
First Posted (Actual)
February 25, 2026
Study Record Updates
Last Update Posted (Actual)
March 10, 2026
Last Update Submitted That Met QC Criteria
March 7, 2026
Last Verified
December 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- FSG pilot project
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dissociative Identity Disorder
-
Centre Psychothérapique de NancyRecruitingDissociative DisorderFrance
-
Yolanda Schlumpf, PhDUniversity of Zurich; Clienia Littenheid AGCompletedComplex Posttraumatic Stress Disorder (cPTSD) | Dissociative Disorder Not Otherwise Specified (DDNOS) | Dissociative Identity Disorder (DID)Switzerland
-
Modum BadCompletedPosttraumatic Stress Disorder | Dissociative Identity Disorder | Dissociative DisorderNorway
-
Mclean HospitalEnrolling by invitationPosttraumatic Stress Disorders | Dissociative Identity DisorderUnited States
-
Universitätsklinikum Hamburg-EppendorfUnknownGender Dysphoria | Gender Identity | Transsexualism | Gender Identity DisorderGermany
-
University of Colorado, DenverCompletedGender Dysphoria | Gender Identity | Gender Identity Disorder in Adolescence and AdulthoodUnited States
-
Weill Medical College of Cornell UniversityIcahn School of Medicine at Mount Sinai; The Cleveland Clinic; Boston Medical...UnknownGender Identity Disorder of Adult | Voiding Disorders | Sexual DysfunctionUnited States
-
Universitätsklinikum Hamburg-EppendorfCompletedGender Dysphoria | Gender Identity | Transsexualism | Gender Identity Disorder | Gender IncongruenceGermany
-
University Hospital, ToursRecruitingDissociative DisorderFrance
-
King's College LondonUniversity of Sheffield; University of Edinburgh; South London and Maudsley NHS... and other collaboratorsCompletedConversion Disorder | Dissociative Disorder | Convulsion, NonepilepticUnited Kingdom
Clinical Trials on Psychotherapy
-
Universidade Federal do Rio de JaneiroCompleted
-
Koç UniversityCompletedBreast Cancer Patients DiagnosedTurkey (Türkiye)
-
Hopital MontfortThe Ottawa HospitalCompletedDepression | Parkinson's DiseaseCanada
-
Istituto per la Ricerca e l'Innovazione BiomedicaIstituto di Gestalt HCC Italy - Centro Clinico e di Ricerca in Psicoterapia...RecruitingRelationship, Professional PatientItaly
-
Hospital de Clinicas de Porto AlegreRecruitingDepression | Interpersonal RelationsBrazil
-
Khushal Khan Khattak Univeristy, Karak, PakistanRecruitingMajor Depressive Disorder 1Pakistan
-
Natalia Dewi Wardani, MDFaculty of Medicine University of Diponegoro, IndonesiaCompletedBorderline Personality Disorder (BPD)Indonesia
-
Randi UlbergUniversity of OsloCompleted
-
Centre Hospitalier Régional Metz-ThionvilleCentral Hospital, Nancy, France; University of LorraineCompletedBreast Cancer FemaleFrance
-
New York State Psychiatric InstituteCompleted